Inventor · disambiguated record
Melissa Kotterman
Also filed as: KOTTERMAN MELISSA · KOTTERMAN MELISSA A
20 granted patents·12 pending applications·44 citations·filing 2014–2024
93Inventor score
Files with4D MOLECULAR THERAPEUTICS INC26UNIV CALIFORNIA4IGNITE IMMUNOTHERAPY INC1IRIS MEDICINE INC1
Top patents by PatentIndex Score
32 records- 0197US11613766B2Adeno-associated virus variant capsids and methods of use thereof4D MOLECULAR THERAPEUTICS INC·Filed 2022·Granted Mar 28, 2023·4 cites·20 claims
- 0297US11167041B2Adeno-associated virus variant capsids and methods of use thereof4D MOLECULAR THERAPEUTICS INC·Filed 2020·Granted Nov 9, 2021·8 cites·6 claims
- 0396US11118192B2Adeno-associated virus variant capsids and methods of use thereof4D MOLECULAR THERAPEUTICS INC·Filed 2018·Granted Sep 14, 2021·15 cites·31 claims
- 0495US11802278B2Codon optimized GLA genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2022·Granted Oct 31, 2023·3 cites·10 claims
- 0593US11198858B2Codon optimized GLA genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2021·Granted Dec 14, 2021·2 cites·23 claims
- 0692US11345930B2Codon optimized RPGRORF15 genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2021·Granted May 31, 2022·2 cites·25 claims
- 0789US11634691B2Compositions and methods of treatmentUNIV CALIFORNIA·Filed 2022·Granted Apr 25, 2023·1 cites·20 claims
- 0889US11499166B2Adeno-associated variants, formulations and methods for pulmonary delivery4D MOLECULAR THERAPEUTICS INC·Filed 2021·Granted Nov 15, 2022·2 cites·12 claims
- 0988US11807868B2Adeno-associated variants, formulations and methods for pulmonary delivery4D MOLECULAR THERAPEUTICS INC·Filed 2022·Granted Nov 7, 2023·1 cites·28 claims
- 1088US11766489B2Adeno-associated virus variant capsids and use for inhibiting angiogenesis4D MOLECULAR THERAPEUTICS INC·Filed 2018·Granted Sep 26, 2023·5 cites·33 claims
- 1187US2024066145A1Adeno-associated virus variant capsids with improved retinal transduction and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1287US2024358859A1Codon optimized rep1 genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1386US11766487B2Treatments for retinal disease4D MOLECULAR THERAPEUTICS INC·Filed 2022·Granted Sep 26, 2023·0 cites·15 claims
- 1484US11840704B2Adeno-associated virus variant capsids and methods of use thereof4D MOLECULAR THERAPEUTICS INC·Filed 2022·Granted Dec 12, 2023·0 cites·20 claims
- 1583US11576983B2Treatments for retinal disease4D MOLECULAR THERAPEUTICS INC·Filed 2022·Granted Feb 14, 2023·0 cites·18 claims
- 1681US2023323311A1Compositions and Methods of TreatmentUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1780US11524081B2Codon optimized REP1 genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2022·Granted Dec 13, 2022·0 cites·20 claims
- 1879US2024018498A1Codon optimized gla genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1979US2023158172A1Codon optimized rep1 genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2078US12221616B2Adeno-associated virus variant capsids and methods of use thereof4D MOLECULAR THERAPEUTICS INC·Filed 2021·Granted Feb 11, 2025·0 cites·20 claims
- 2178US11357870B2Codon optimized REP1 genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2021·Granted Jun 14, 2022·0 cites·25 claims
- 2277US11419949B2Adeno-associated virus variant capsids and methods of use thereof4D MOLECULAR THERAPEUTICS INC·Filed 2021·Granted Aug 23, 2022·0 cites·6 claims
- 2377US11136557B2Adeno-associated virus variants and methods of use thereofUNIV CALIFORNIA·Filed 2014·Granted Oct 5, 2021·1 cites·9 claims
- 2476US11179477B2Method of using adeno-associated virus with variant capsid4D MOLECULAR THERAPEUTICS INC·Filed 2020·Granted Nov 23, 2021·0 cites·6 claims
- 2575US2024067987A1Adeno-associated variants, formulations and methods for pulmonary delivery4D MOLECULAR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2674US2022017876A1Adeno-associated virus variants and methods of use thereofUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 2772US11364308B2Adeno-associated virus variant capsids and methods of use thereof4D MOLECULAR THERAPEUTICS INC·Filed 2017·Granted Jun 21, 2022·0 cites·15 claims
- 2868US2022290181A1Codon optimized rpgrorf15 genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2967US2025163469A1Adeno-associated virus variant capsids and methods of use thereof4D MOLECULAR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3064US2024335560A1Adeno-associated virus variant capsids and use for inhibiting angiogenesis4D MOLECULAR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3157US2024425856A1Compositions and Methods for Treating Cag Repeat DiseasesIRIS MEDICINE INC·Filed 2022·Application pending·0 cites
- 3248US2023002740A1Variant oncolytic vaccinia virus and methods of use thereofIGNITE IMMUNOTHERAPY INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Melissa Kotterman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →